| # | Drug | Count |
|---|---|---|
| 0 | ICATIBANT | 57 |
| 1 | IDURSULFASE | 47 |
| 2 | LANADELUMAB-FLYO | 34 |
| 3 | TEDUGLUTIDE | 30 |
| 4 | VEDOLIZUMAB | 30 |
| 5 | OMEPRAZOLE MAGNESIUM | 17 |
| 6 | ERGOCALCIFEROL | 14 |
| 7 | METFORMIN | 14 |
| 8 | OMEPRAZOLE | 14 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDURSULFASE | 47 | 0.0118 |
| 1 | LANADELUMAB-FLYO | 34 | 0.0105 |
| 2 | VELAGLUCERASE ALFA | 7 | 0.0034 |
| 3 | DEFLAZACORT | 7 | 0.0027 |
| 4 | TEDUGLUTIDE | 30 | 0.0022 |
| 5 | DANAZOL | 6 | 0.0021 |
| 6 | TRIPTORELIN | 7 | 0.0021 |
| 7 | ICATIBANT ACETATE | 6 | 0.0010 |
| 8 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 3 | 0.0007 |
| 9 | DEXMETHYLPHENIDATE HYDROCHLORIDE | 3 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 34 | 0.0142 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 47 | 0.0035 |
| 2 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 3 | GLP-2 Analog [EPC] | 30 | 0.0022 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 7 | 0.0010 |
| 6 | Human C1 Esterase Inhibitor [EPC] | 3 | 0.0008 |
| 7 | Interferon gamma [EPC] | 1 | 0.0007 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 7 | 0.0007 |
| 9 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |